Try our beta test site
Trial record 1 of 4 for:    04-21
Previous Study | Return to List | Next Study

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts (ONTIME)

This study is ongoing, but not recruiting participants.
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
Onconova Therapeutics, Inc. Identifier:
First received: November 1, 2010
Last updated: November 29, 2016
Last verified: November 2016